Found 165 hits with Last Name = 'onishi' and Initial = 't' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50101813
(CHEBI:31399 | Cilnidipine)Show SMILES COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\C=C\c1ccccc1 |c:7,12| Show InChI InChI=1S/C27H28N2O7/c1-18-23(26(30)35-14-8-11-20-9-5-4-6-10-20)25(21-12-7-13-22(17-21)29(32)33)24(19(2)28-18)27(31)36-16-15-34-3/h4-13,17,25,28H,14-16H2,1-3H3/b11-8+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet 
| Purchase
DrugBank
MCE
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibition of voltage-dependent L-type calcium channel in rat thoracic aorta ring assessed as effect on high K+ induced contraction by Magnus method |
Bioorg Med Chem Lett 18: 4813-6 (2008)
Article DOI: 10.1016/j.bmcl.2008.07.096
BindingDB Entry DOI: 10.7270/Q208684R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50101813
(CHEBI:31399 | Cilnidipine)Show SMILES COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\C=C\c1ccccc1 |c:7,12| Show InChI InChI=1S/C27H28N2O7/c1-18-23(26(30)35-14-8-11-20-9-5-4-6-10-20)25(21-12-7-13-22(17-21)29(32)33)24(19(2)28-18)27(31)36-16-15-34-3/h4-13,17,25,28H,14-16H2,1-3H3/b11-8+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| Purchase
DrugBank
MCE
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475660
(CHEMBL201566)Show SMILES C\C(CO\C(O)=C1\C(C(C(O)=O)=C(C)N=C1C)c1cccc(Cl)c1)=C/c1ccccc1 |c:14,t:11| Show InChI InChI=1S/C25H24ClNO4/c1-15(12-18-8-5-4-6-9-18)14-31-25(30)22-17(3)27-16(2)21(24(28)29)23(22)19-10-7-11-20(26)13-19/h4-13,23,30H,14H2,1-3H3,(H,28,29)/b15-12+,25-22+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475658
(CHEMBL201984)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OC\C=C\C1CCCCC1)c1cccc(Cl)c1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C24H28ClNO4/c1-15-20(23(27)28)22(18-11-6-12-19(25)14-18)21(16(2)26-15)24(29)30-13-7-10-17-8-4-3-5-9-17/h6-7,10-12,14,17,22,29H,3-5,8-9,13H2,1-2H3,(H,27,28)/b10-7+,24-21+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475653
(CHEMBL382528)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OC\C=C\c1ccc(Cl)cc1)c1cccc(Cl)c1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C24H21Cl2NO4/c1-14-20(23(28)29)22(17-6-3-7-19(26)13-17)21(15(2)27-14)24(30)31-12-4-5-16-8-10-18(25)11-9-16/h3-11,13,22,30H,12H2,1-2H3,(H,28,29)/b5-4+,24-21+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 5.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475650
(CHEMBL203041)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OC\C=C\c1ccc(C)cc1)c1cccc(Cl)c1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C25H24ClNO4/c1-15-9-11-18(12-10-15)6-5-13-31-25(30)22-17(3)27-16(2)21(24(28)29)23(22)19-7-4-8-20(26)14-19/h4-12,14,23,30H,13H2,1-3H3,(H,28,29)/b6-5+,25-22+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 6.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50479255
(CHEMBL453084)Show SMILES CCC1=C(C(C(C(O)=O)=C(C)N1)c1cccc(Cl)c1)C(=O)OC\C=C\c1ccccc1 |t:2,8| Show InChI InChI=1S/C25H24ClNO4/c1-3-20-23(25(30)31-14-8-11-17-9-5-4-6-10-17)22(18-12-7-13-19(26)15-18)21(24(28)29)16(2)27-20/h4-13,15,22,27H,3,14H2,1-2H3,(H,28,29)/b11-8+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibition of voltage-dependent L-type calcium channel in rat thoracic aorta ring assessed as effect on high K+ induced contraction by Magnus method |
Bioorg Med Chem Lett 18: 4813-6 (2008)
Article DOI: 10.1016/j.bmcl.2008.07.096
BindingDB Entry DOI: 10.7270/Q208684R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475663
(CHEMBL202464)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OC\C=C\c1ccccc1)c1ccccc1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C24H23NO4/c1-16-20(23(26)27)22(19-13-7-4-8-14-19)21(17(2)25-16)24(28)29-15-9-12-18-10-5-3-6-11-18/h3-14,22,28H,15H2,1-2H3,(H,26,27)/b12-9+,24-21+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475664
(CHEMBL369934)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OC\C=C\c1ccccc1)c1cccc(Br)c1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C24H22BrNO4/c1-15-20(23(27)28)22(18-11-6-12-19(25)14-18)21(16(2)26-15)24(29)30-13-7-10-17-8-4-3-5-9-17/h3-12,14,22,29H,13H2,1-2H3,(H,27,28)/b10-7+,24-21+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475672
(CHEMBL201057)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OC\C=C\c1ccccc1)c1cccc(I)c1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C24H22INO4/c1-15-20(23(27)28)22(18-11-6-12-19(25)14-18)21(16(2)26-15)24(29)30-13-7-10-17-8-4-3-5-9-17/h3-12,14,22,29H,13H2,1-2H3,(H,27,28)/b10-7+,24-21+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299079
(5-{3-[4-(Methylsulfinyl)phenyl]-1-benzofuran-5-yl}...)Show SMILES CS(=O)c1ccc(cc1)-c1coc2ccc(cc12)-c1nnc(N)o1 Show InChI InChI=1S/C17H13N3O3S/c1-24(21)12-5-2-10(3-6-12)14-9-22-15-7-4-11(8-13(14)15)16-19-20-17(18)23-16/h2-9H,1H3,(H2,18,20) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475662
(CHEMBL201860)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OCc1ccc2ccccc2c1)c1cccc(Cl)c1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C26H22ClNO4/c1-15-22(25(29)30)24(20-8-5-9-21(27)13-20)23(16(2)28-15)26(31)32-14-17-10-11-18-6-3-4-7-19(18)12-17/h3-13,24,31H,14H2,1-2H3,(H,29,30)/b26-23+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299083
((S)-3-(4-(ethylsulfinyl)phenyl)-5-(5-methylfuran-2...)Show SMILES CC[S@](=O)c1ccc(cc1)-c1coc2ccc(cc12)-c1ccc(C)o1 |r| Show InChI InChI=1S/C21H18O3S/c1-3-25(22)17-8-5-15(6-9-17)19-13-23-21-11-7-16(12-18(19)21)20-10-4-14(2)24-20/h4-13H,3H2,1-2H3/t25-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475669
(CHEMBL382072)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OC\C=C\c1ccccc1)c1cccc(Cl)c1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C24H22ClNO4/c1-15-20(23(27)28)22(18-11-6-12-19(25)14-18)21(16(2)26-15)24(29)30-13-7-10-17-8-4-3-5-9-17/h3-12,14,22,29H,13H2,1-2H3,(H,27,28)/b10-7+,24-21+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibition of voltage-dependent L-type calcium channel in rat thoracic aorta ring assessed as effect on high K+ induced contraction by Magnus method |
Bioorg Med Chem Lett 18: 4813-6 (2008)
Article DOI: 10.1016/j.bmcl.2008.07.096
BindingDB Entry DOI: 10.7270/Q208684R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475669
(CHEMBL382072)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OC\C=C\c1ccccc1)c1cccc(Cl)c1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C24H22ClNO4/c1-15-20(23(27)28)22(18-11-6-12-19(25)14-18)21(16(2)26-15)24(29)30-13-7-10-17-8-4-3-5-9-17/h3-12,14,22,29H,13H2,1-2H3,(H,27,28)/b10-7+,24-21+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475656
(CHEMBL201306)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OC\C=C\c1ccccc1)c1cccc(F)c1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C24H22FNO4/c1-15-20(23(27)28)22(18-11-6-12-19(25)14-18)21(16(2)26-15)24(29)30-13-7-10-17-8-4-3-5-9-17/h3-12,14,22,29H,13H2,1-2H3,(H,27,28)/b10-7+,24-21+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475661
(CHEMBL204486)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OC\C=C\c1ccccc1)c1ccccc1[N+]([O-])=O)C(O)=O |c:4,t:1| Show InChI InChI=1S/C24H22N2O6/c1-15-20(23(27)28)22(18-12-6-7-13-19(18)26(30)31)21(16(2)25-15)24(29)32-14-8-11-17-9-4-3-5-10-17/h3-13,22,29H,14H2,1-2H3,(H,27,28)/b11-8+,24-21+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299081
((S)-5-(5-methylfuran-2-yl)-3-(4-(methylsulfinyl)ph...)Show SMILES Cc1ccc(o1)-c1ccc2occ(-c3ccc(cc3)[S@](C)=O)c2c1 |r| Show InChI InChI=1S/C20H16O3S/c1-13-3-9-19(23-13)15-6-10-20-17(11-15)18(12-22-20)14-4-7-16(8-5-14)24(2)21/h3-12H,1-2H3/t24-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299082
((R)-3-(4-(ethylsulfinyl)phenyl)-5-(5-methylfuran-2...)Show SMILES CC[S@@](=O)c1ccc(cc1)-c1coc2ccc(cc12)-c1ccc(C)o1 |r| Show InChI InChI=1S/C21H18O3S/c1-3-25(22)17-8-5-15(6-9-17)19-13-23-21-11-7-16(12-18(19)21)20-10-4-14(2)24-20/h4-13H,3H2,1-2H3/t25-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299080
((R)-5-(5-methylfuran-2-yl)-3-(4-(methylsulfinyl)ph...)Show SMILES Cc1ccc(o1)-c1ccc2occ(-c3ccc(cc3)[S@@](C)=O)c2c1 |r| Show InChI InChI=1S/C20H16O3S/c1-13-3-9-19(23-13)15-6-10-20-17(11-15)18(12-22-20)14-4-7-16(8-5-14)24(2)21/h3-12H,1-2H3/t24-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299084
(2-{3-[4-(Ethylsulfonyl)phenyl]-1-benzofuran-5-yl}-...)Show SMILES CCS(=O)(=O)c1ccc(cc1)-c1coc2ccc(cc12)-c1ccc(C)o1 Show InChI InChI=1S/C21H18O4S/c1-3-26(22,23)17-8-5-15(6-9-17)19-13-24-21-11-7-16(12-18(19)21)20-10-4-14(2)25-20/h4-13H,3H2,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299085
(2-Methyl-5-{3-[4-(methylsulfonyl)phenyl]-1-benzofu...)Show SMILES Cc1ccc(o1)-c1ccc2occ(-c3ccc(cc3)S(C)(=O)=O)c2c1 Show InChI InChI=1S/C20H16O4S/c1-13-3-9-19(24-13)15-6-10-20-17(11-15)18(12-23-20)14-4-7-16(8-5-14)25(2,21)22/h3-12H,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475671
(CHEMBL382236)Show SMILES CC1=NC(C)=C(C(c2ccsc2)\C1=C(/O)OC\C=C\c1ccccc1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C22H21NO4S/c1-14-18(21(24)25)20(17-10-12-28-13-17)19(15(2)23-14)22(26)27-11-6-9-16-7-4-3-5-8-16/h3-10,12-13,20,26H,11H2,1-2H3,(H,24,25)/b9-6+,22-19+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475659
(CHEMBL508181)Show SMILES CC1=C(C(C(C(=O)OC\C=C\c2ccccc2)=C(C)N1)c1cccc(c1)[N+]([O-])=O)C(O)=O |t:1,17| Show InChI InChI=1S/C24H22N2O6/c1-15-20(23(27)28)22(18-11-6-12-19(14-18)26(30)31)21(16(2)25-15)24(29)32-13-7-10-17-8-4-3-5-9-17/h3-12,14,22,25H,13H2,1-2H3,(H,27,28)/b10-7+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibition of voltage-dependent L-type calcium channel in rat thoracic aorta ring assessed as effect on high K+ induced contraction by Magnus method |
Bioorg Med Chem Lett 18: 4813-6 (2008)
Article DOI: 10.1016/j.bmcl.2008.07.096
BindingDB Entry DOI: 10.7270/Q208684R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475659
(CHEMBL508181)Show SMILES CC1=C(C(C(C(=O)OC\C=C\c2ccccc2)=C(C)N1)c1cccc(c1)[N+]([O-])=O)C(O)=O |t:1,17| Show InChI InChI=1S/C24H22N2O6/c1-15-20(23(27)28)22(18-11-6-12-19(14-18)26(30)31)21(16(2)25-15)24(29)32-13-7-10-17-8-4-3-5-9-17/h3-12,14,22,25H,13H2,1-2H3,(H,27,28)/b10-7+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475648
(CHEMBL202605)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OCC(=O)Nc1ccccc1)c1cccc(Cl)c1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C23H21ClN2O5/c1-13-19(22(28)29)21(15-7-6-8-16(24)11-15)20(14(2)25-13)23(30)31-12-18(27)26-17-9-4-3-5-10-17/h3-11,21,30H,12H2,1-2H3,(H,26,27)(H,28,29)/b23-20+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299086
(4-[5-(5-Methyl-1,3,4-oxadiazol-2-yl)-1-benzofuran-...)Show SMILES Cc1ccc(o1)-c1ccc2occ(-c3ccc(cc3)C(O)=O)c2c1 Show InChI InChI=1S/C20H14O4/c1-12-2-8-18(24-12)15-7-9-19-16(10-15)17(11-23-19)13-3-5-14(6-4-13)20(21)22/h2-11H,1H3,(H,21,22) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299087
(2-[3-(4-Methoxyphenyl)-1-benzofuran-5-yl]-5-methyl...)Show InChI InChI=1S/C20H16O3/c1-13-3-9-19(23-13)15-6-10-20-17(11-15)18(12-22-20)14-4-7-16(21-2)8-5-14/h3-12H,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299088
(2-Methyl-5-{3-[4-(methylsulfanyl)phenyl]-1-benzofu...)Show InChI InChI=1S/C20H16O2S/c1-13-3-9-19(22-13)15-6-10-20-17(11-15)18(12-21-20)14-4-7-16(23-2)8-5-14/h3-12H,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 66 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299089
(4-[5-(5-Methyl-1,3,4-oxadiazol-2-yl)-1-benzofuran-...)Show SMILES Cc1ccc(o1)-c1ccc2occ(-c3ccc(cc3)C(N)=O)c2c1 Show InChI InChI=1S/C20H15NO3/c1-12-2-8-18(24-12)15-7-9-19-16(10-15)17(11-23-19)13-3-5-14(6-4-13)20(21)22/h2-11H,1H3,(H2,21,22) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 69 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299072
(2-Methyl-5-{3-[4-(methylsulfinyl)phenyl]-1-benzofu...)Show SMILES Cc1nnc(s1)-c1ccc2occ(-c3ccc(cc3)S(C)=O)c2c1 Show InChI InChI=1S/C18H14N2O2S2/c1-11-19-20-18(23-11)13-5-8-17-15(9-13)16(10-22-17)12-3-6-14(7-4-12)24(2)21/h3-10H,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 72 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299090
(2-[3-(3-Methoxyphenyl)-1-benzofuran-5-yl]-5-methyl...)Show InChI InChI=1S/C20H16O3/c1-13-6-8-19(23-13)15-7-9-20-17(11-15)18(12-22-20)14-4-3-5-16(10-14)21-2/h3-12H,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475668
(CHEMBL202374)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OC\C=C\c1ccccc1)c1cccc(C)c1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C25H25NO4/c1-16-9-7-13-20(15-16)23-21(24(27)28)17(2)26-18(3)22(23)25(29)30-14-8-12-19-10-5-4-6-11-19/h4-13,15,23,29H,14H2,1-3H3,(H,27,28)/b12-8+,25-22+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 76 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299091
(4-[5-(5-Methyl-1,3,4-oxadiazol-2-yl)-1-benzofuran-...)Show InChI InChI=1S/C18H13NO2/c1-12-2-4-17(21-12)14-3-5-18-15(10-14)16(11-20-18)13-6-8-19-9-7-13/h2-11H,1H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 77 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299073
(3-Methyl-5-{3-[4-(methylsulfinyl)phenyl]-1-benzofu...)Show SMILES Cc1nnc([nH]1)-c1ccc2occ(-c3ccc(cc3)S(C)=O)c2c1 Show InChI InChI=1S/C18H15N3O2S/c1-11-19-18(21-20-11)13-5-8-17-15(9-13)16(10-23-17)12-3-6-14(7-4-12)24(2)22/h3-10H,1-2H3,(H,19,20,21) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 81 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299077
(5-{3-[4-(Methylsulfinyl)phenyl]-1-benzofuran-5-yl}...)Show SMILES CS(=O)c1ccc(cc1)-c1coc2ccc(cc12)-c1nnc(S)o1 Show InChI InChI=1S/C17H12N2O3S2/c1-24(20)12-5-2-10(3-6-12)14-9-21-15-7-4-11(8-13(14)15)16-18-19-17(23)22-16/h2-9H,1H3,(H,19,23) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 94 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299092
(1-{4-[5-(5-Methyl-1,3,4-oxadiazol-2-yl)-1-benzofur...)Show SMILES CC(=O)c1ccc(cc1)-c1coc2ccc(cc12)-c1ccc(C)o1 Show InChI InChI=1S/C21H16O3/c1-13-3-9-20(24-13)17-8-10-21-18(11-17)19(12-23-21)16-6-4-15(5-7-16)14(2)22/h3-12H,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299093
(2-[3-(4-Fluorophenyl)-1-benzofuran-5-yl]-5-methyl-...)Show InChI InChI=1S/C19H13FO2/c1-12-2-8-18(22-12)14-5-9-19-16(10-14)17(11-21-19)13-3-6-15(20)7-4-13/h2-11H,1H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475667
(CHEMBL382629)Show SMILES CC1=NC(C)=C(C(c2ccoc2)\C1=C(/O)OC\C=C\c1ccccc1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C22H21NO5/c1-14-18(21(24)25)20(17-10-12-27-13-17)19(15(2)23-14)22(26)28-11-6-9-16-7-4-3-5-8-16/h3-10,12-13,20,26H,11H2,1-2H3,(H,24,25)/b9-6+,22-19+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299078
(5-{3-[4-(Methylsulfinyl)phenyl]-1-benzofuran-5-yl}...)Show SMILES CS(=O)c1ccc(cc1)-c1coc2ccc(cc12)-c1n[nH]c(=O)o1 Show InChI InChI=1S/C17H12N2O4S/c1-24(21)12-5-2-10(3-6-12)14-9-22-15-7-4-11(8-13(14)15)16-18-19-17(20)23-16/h2-9H,1H3,(H,19,20) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299080
((R)-5-(5-methylfuran-2-yl)-3-(4-(methylsulfinyl)ph...)Show SMILES Cc1ccc(o1)-c1ccc2occ(-c3ccc(cc3)[S@@](C)=O)c2c1 |r| Show InChI InChI=1S/C20H16O3S/c1-13-3-9-19(23-13)15-6-10-20-17(11-15)18(12-22-20)14-4-7-16(8-5-14)24(2)21/h3-12H,1-2H3/t24-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299094
(1-{4-[5-(5-Methyl-1,3,4-oxadiazol-2-yl)-1-benzofur...)Show InChI InChI=1S/C21H18O3/c1-13-3-9-20(24-13)17-8-10-21-18(11-17)19(12-23-21)16-6-4-15(5-7-16)14(2)22/h3-12,14,22H,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299095
(4-[5-(5-Methyl-1,3,4-oxadiazol-2-yl)-1-benzofuran-...)Show InChI InChI=1S/C19H14O3/c1-12-2-8-18(22-12)14-5-9-19-16(10-14)17(11-21-19)13-3-6-15(20)7-4-13/h2-11,20H,1H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299082
((R)-3-(4-(ethylsulfinyl)phenyl)-5-(5-methylfuran-2...)Show SMILES CC[S@@](=O)c1ccc(cc1)-c1coc2ccc(cc12)-c1ccc(C)o1 |r| Show InChI InChI=1S/C21H18O3S/c1-3-25(22)17-8-5-15(6-9-17)19-13-23-21-11-7-16(12-18(19)21)20-10-4-14(2)24-20/h4-13H,3H2,1-2H3/t25-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475649
(CHEMBL203470)Show SMILES CC1=NC(C)=C(C(\C1=C(/O)OC\C=C\c1ccccc1)c1cccnc1)C(O)=O |c:4,t:1| Show InChI InChI=1S/C23H22N2O4/c1-15-19(22(26)27)21(18-11-6-12-24-14-18)20(16(2)25-15)23(28)29-13-7-10-17-8-4-3-5-9-17/h3-12,14,21,28H,13H2,1-2H3,(H,26,27)/b10-7+,23-20+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Voltage-dependent L-type calcium channel subunit alpha-1S
(Rattus norvegicus) | BDBM50475670
(CHEMBL372748)Show SMILES [#6]-[#6]1=[#7]-[#6](-[#6])=[#6](-[#6](\[#6]-1=[#6](/[#8])-[#8]-[#6]\[#6]=[#6](/c1ccccc1)-c1ccccc1)-c1cccc(Cl)c1)-[#6](-[#8])=O |c:4,t:1| Show InChI InChI=1S/C30H26ClNO4/c1-19-26(29(33)34)28(23-14-9-15-24(31)18-23)27(20(2)32-19)30(35)36-17-16-25(21-10-5-3-6-11-21)22-12-7-4-8-13-22/h3-16,18,28,35H,17H2,1-2H3,(H,33,34)/b30-27+ | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Ajinomoto company Inc.
Curated by ChEMBL
| Assay Description
Inhibitory activity against L-type calcium channel in SD rat thoracic aorta by Magnus method |
Bioorg Med Chem Lett 16: 798-802 (2006)
Article DOI: 10.1016/j.bmcl.2005.11.021
BindingDB Entry DOI: 10.7270/Q2NP276R |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299099
(6-(5-Methyl-1,3,4-oxadiazol-2-yl)-1-[4-(methylsulf...)Show SMILES Cc1ccc(o1)-c1ccc2ncn(-c3ccc(cc3)S(C)=O)c2c1 Show InChI InChI=1S/C19H16N2O2S/c1-13-3-10-19(23-13)14-4-9-17-18(11-14)21(12-20-17)15-5-7-16(8-6-15)24(2)22/h3-12H,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299096
(CHEMBL573480 | Methyl 4-[5-(5-Methyl-1,3,4-oxadiaz...)Show SMILES COC(=O)c1ccc(cc1)-c1coc2ccc(cc12)-c1ccc(C)o1 Show InChI InChI=1S/C21H16O4/c1-13-3-9-19(25-13)16-8-10-20-17(11-16)18(12-24-20)14-4-6-15(7-5-14)21(22)23-2/h3-12H,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299097
(2-Methyl-5-{3-[3-(methylsulfinyl)phenyl]-1-benzofu...)Show SMILES Cc1ccc(o1)-c1ccc2occ(-c3cccc(c3)S(C)=O)c2c1 Show InChI InChI=1S/C20H16O3S/c1-13-6-8-19(23-13)15-7-9-20-17(11-15)18(12-22-20)14-4-3-5-16(10-14)24(2)21/h3-12H,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50299102
(5-(5-Methyl-1,3,4-oxadiazol-2-yl)-3-[4-(methylsulf...)Show SMILES Cc1ccc(o1)-c1ccc2occ(-c3ccc(cc3)S(C)=O)c2n1 Show InChI InChI=1S/C19H15NO3S/c1-12-3-9-17(23-12)16-8-10-18-19(20-16)15(11-22-18)13-4-6-14(7-5-13)24(2)21/h3-11H,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 270 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3-beta |
J Med Chem 52: 6270-86 (2009)
Article DOI: 10.1021/jm900647e
BindingDB Entry DOI: 10.7270/Q2CZ377V |
More data for this
Ligand-Target Pair | |
Search and Browse
